Literature DB >> 10836321

Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds.

L Greiff1, M Andersson, C Svensson, M Linden, S Myint, C G Persson.   

Abstract

Rhinovirus infections cause exacerbations of eosinophilic airway disease. The acute effects of allergen-challenge on nasal interleukin-8 (IL-8), eosinophil cationic protein (ECP), and alpha2-macroglobulin were examined in atopic subjects with common cold symptoms. Twenty-three patients with seasonal allergic rhinitis were inoculated with human rhinovirus 16 outside the pollen season. Diluent and allergen challenges, followed by nasal lavages, were carried out about 3 months before and 4 days after virus inoculation. Seventeen patients developed significant common cold symptoms with increased nasal lavage fluid levels of alpha2-macroglobulin, IL-8, and ECP at baseline (p<0.001-0.05 versus before inoculation), and were further increased by allergen challenge (p< 0.001-0.05); IL-8 and ECP levels were correlated (r = 0.63, p<0.001). Before inoculation, the six patients who later did not develop common cold symptoms had high levels of IL-8 and myeloperoxidase (MPO), and exhibited strong allergen-induced plasma exudation responses (alpha2-macroglobulin). After inoculation, IL-8 and ECP did not increase in these symptomless subjects. In conclusion, high nasal interleukin-8 and myeloperoxidase levels and exudative hyperresponsiveness may protect against infection. The association between nasal interleukin-8 and eosinophil cationic protein in common cold, particularly that observed in nasal lavage fluids after allergen-induced acute exudation of plasma, suggests the involvement of interleukin-8 in exacerbation of airway mucosal eosinophil activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10836321     DOI: 10.1183/09031936.99.13104199

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Defensin and chemokine expression patterns in the palatine tonsil: a model of their local interaction.

Authors:  Jens Eduard Meyer; Ulf Henning Beier; Tibor Görögh; Sebastian Schreiber; Christian Beck; Steffen Maune
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-13       Impact factor: 2.503

Review 2.  Humoral First-Line Mucosal Innate Defence in vivo.

Authors:  Carl Persson
Journal:  J Innate Immun       Date:  2020-03-23       Impact factor: 7.349

3.  Allergen challenge in vivo alters rhinovirus-induced chemokine secretion from human airway macrophages.

Authors:  Maya R Karta; Lisa E Wickert; Colleen S Curran; Monica L Gavala; Loren C Denlinger; James E Gern; Paul J Bertics
Journal:  J Allergy Clin Immunol       Date:  2014-02-14       Impact factor: 10.793

4.  Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis.

Authors:  Lennart Greiff; Anders Cervin; Cecilia Ahlström-Emanuelsson; Gun Almqvist; Morgan Andersson; Jan Dolata; Leif Eriksson; Edward Högestätt; Anders Källén; Per Norlén; Inga-Lisa Sjölin; Henrik Widegren
Journal:  Respir Res       Date:  2012-06-22

Review 5.  Rhinoviruses in the pathogenesis of asthma.

Authors:  Nikolaos G Papadopoulos; Stelios Psarras
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

6.  Persistent airway obstruction after virus infection is not associated with airway inflammation.

Authors:  Lisa G Wood; Heather Powell; Terry Grissell; Thuy T D Nguyen; Darren Shafren; Michael Hensley; Peter G Gibson
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

Review 7.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

8.  An adult model of exclusive viral wheeze: inflammation in the upper and lower respiratory tracts.

Authors:  M C Mckean; C Hewitt; P C Lambert; St Myint; M Silverman
Journal:  Clin Exp Allergy       Date:  2003-07       Impact factor: 5.018

Review 9.  Mechanisms of rhinovirus-induced asthma.

Authors:  Nikolaos G Papadopoulos; Alberto Papi; Stelios Psarras; Sebastian L Johnston
Journal:  Paediatr Respir Rev       Date:  2004-09       Impact factor: 2.726

10.  Inhaled dsRNA and rhinovirus evoke neutrophilic exacerbation and lung expression of thymic stromal lymphopoietin in allergic mice with established experimental asthma.

Authors:  I Mahmutovic-Persson; H Akbarshahi; N W Bartlett; N Glanville; S L Johnston; A Brandelius; L Uller
Journal:  Allergy       Date:  2013-11-28       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.